Register for this CME-certified symposium
6th Annual Clinical Care Options Hepatitis Symposium
May 29 - June 1, 2008
Hotel del Coronado
Coronado, California
The 6th Annual Clinical Care Options Hepatitis Symposium is designed for participants to synthesize the advancements of the previous year and to discuss state-of-the-art treatment strategies with leading experts and colleagues in a setting that is conducive to both formal learning and informal networking.
Agenda
THURSDAY, MAY 29, 2008
12:00 PM - 6:00 PM – Registration
6:00 PM - 10:00 PM – Welcome Reception
FRIDAY, MAY 30, 2008
7:00 AM – Continental Breakfast
New this year: Interact informally with selected faculty at topic-based “breakfast with the faculty” tables
7:45 AM – Plenary Session
Welcome, Opening Remarks, and Day 1 Overview
Co-Chair: Marion G. Peters, MD, FRACP
8:00 AM
Can Hepatitis B Be Cured?
Speaker: Marc G. Ghany, MD
Bethesda, Maryland
8:20 AM
Therapy of Chronic Hepatitis B: Who to Treat and When to Treat (30 minutes)
Speaker: Anna S. F. Lok, MD
Ann Arbor, Michigan
8:50 AM – Break
9:10 AM
Therapy of Chronic Hepatitis B: What to Choose, When to Stop, and When to Change
Speaker: Ira M. Jacobson, MD
New York, New York
9:50 AM
Case-Based Plenary: Approach to Women With Hepatitis B Who Are Pregnant or Anticipating Pregnancy
Speaker: Tram T. Tran, MD
Los Angeles, California
10:20 AM – Panel
Questions on Morning Plenary Topics
Panelists: Morning speakers
11:00 AM – Break
11:30 AM – 1:00 pm
Interactive Case Challenges 1: HBV
Co-Chair: Marion G. Peters, MD, FRACP
Discussants: Raymond T. Chung, MD; Jules L. Dienstag, MD; Ira M. Jacobson, MD; Anna S. F. Lok, MD
- Approach to the Hepatitis B Patient With Normal ALT
- Managing Hepatitis B in a Cancer/Chemotherapy Patient: When to Start, How Long to Treat, What Therapy?
- Management of a Patient With Suboptimal Response to Anti-HBV Therapy: Switch vs Combination?
1:00 PM – Lunch
Afternoon/Evening
Leisure Activities and Dinner
(on your own)
SATURDAY, MAY 31, 2008
7:00 AM – Continental Breakfast
7:45 AM – Plenary Session
Day 2 Overview
Co-Chair: Mark S. Sulkowski, MD
8:00 AM
New Data on Currently Available HCV Therapies and Their Impact on Initial Treatment Strategies
Speaker: Mark S. Sulkowski, MD
Baltimore, Maryland
8:30 AM
Case-Based Plenary: Maximizing HCV Treatment in Persons With Substance Abuse and Mental Illness
Speaker: Edmund J. Bini, MD, MPH
New York, New York
9:00 AM – Break
9:20 AM
Strategies for Management of Hepatitis C Treatment Failure
Speaker: Karen L. Lindsay, MD, MMM
Los Angeles, California
9:50 AM
HCV Therapy: What Will the Future Look Like?
Speaker: David R. Nelson, MD
Gainesville, Florida
10:20 AM – Panel
Questions on Morning Plenary Topics
Co-Chair: Mark S. Sulkowski, MD
Panelists: Morning speakers
11:00 AM – Break
11:30 AM – 1:00 PM
Interactive Case Challenges 2: HCV
Co-Chair: Adrian Di Bisceglie, MD, FACP
Discussants: Karen L. Lindsay, MD, MMM; David R. Nelson, MD; Mark S. Sulkowski, MD
- Management of an Obese Patient With Chronic Hepatitis C
- Use of Growth Factors During Peginterferon/Ribavirin therapy
- Management of Renal Insufficiency in Hepatitis C
1:00 PM – Lunch
Afternoon/Evening
Leisure Activities and Dinner
(on your own)
SUNDAY, JUNE 1, 2008
7:45 AM – Breakfast
8:30 AM– Plenary Sesssion
Day 3 Overview
Co-Chair: Raymond T. Chung, MD
8:45 AM
Update on Autoimmune Hepatitis: Management Strategies
Speaker: Michael P. Manns, MD
Hanover, Germany
9:15 AM
Managing the Complications of Decompensated Cirrhosis
Speaker: Guadalupe Garcia-Tsao, MD
New Haven, Connecticut
9:45 AM
Hepatitis Journal Club: Top Clinical Articles of 2007-2008
Speaker: Jorge L. Herrera, MD
Mobile, Alabama
10:15 am – Panel
Questions on Morning Plenary Topics
Co-Chair: Raymond T. Chung, MD
Panelists: Morning speakers
10:30 AM
Closing Remarks
Co-Chair:Raymond T. Chung, MD
10:45 AM - Adjournment
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
